IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,836,000
- Total 13F shares
- 18,472,023
- Share change
- +7,545,777
- Total reported value
- $262,487,409
- Price per share
- $14.21
- Number of holders
- 64
- Value change
- +$120,236,682
- Number of buys
- 54
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| 5AM Venture Management, LLC |
13F
|
Company |
3.9%
|
3,463,066
|
$14,268,000 | — | 31 Mar 2020 | |
| Canaan Partners X LLC |
13F
|
Company |
3%
|
2,660,713
|
$10,962,000 | — | 31 Mar 2020 | |
| BVF INC/IL |
13F
|
Company |
1.5%
|
1,284,829
|
$5,293,000 | — | 31 Mar 2020 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.3%
|
1,141,484
|
$4,702,000 | — | 31 Mar 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
0.87%
|
764,252
|
$3,149,000 | — | 31 Mar 2020 | |
| Alphabet Inc. |
13F
|
Company |
0.86%
|
753,187
|
$3,103,000 | — | 31 Mar 2020 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.22%
|
197,615
|
$814,000 | — | 31 Mar 2020 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.2%
|
174,083
|
$717,000 | — | 31 Mar 2020 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.14%
|
126,611
|
$522,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.1%
|
88,518
|
$365,000 | — | 31 Mar 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
85,000
|
$350,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
59,264
|
$244,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
38,218
|
$158,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
26,363
|
$109,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
19,240
|
$79,000 | — | 31 Mar 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.02%
|
17,311
|
$71,000 | — | 31 Mar 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
12,401
|
$51,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
3,096
|
$13,000 | — | 31 Mar 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
1,958
|
$8,000 | — | 31 Mar 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,044
|
$4,000 | — | 31 Mar 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
850
|
$4,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
702
|
$3,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
524
|
$2,000 | — | 31 Mar 2020 | |
| Winslow, Evans & Crocker, Inc. |
13F
|
Company |
0%
|
440
|
$2,000 | — | 31 Mar 2020 | |
| Point72 Hong Kong Ltd |
13F
|
Company |
0%
|
195
|
$1,000 | — | 31 Mar 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
160
|
$1,000 | — | 31 Mar 2020 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q2 2020
As of 30 Jun 2020,
IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,472,023 shares.
The largest 10 holders included
5AM Venture Management, LLC, BVF INC/IL, Canaan Partners X LLC, BOXER CAPITAL, LLC, Avidity Partners Management LP, Point72 Asset Management, L.P., Alphabet Inc., BlackRock Inc., VANGUARD GROUP INC, and CITADEL ADVISORS LLC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
24
Q2 2020 holders
64
Holder diff
40
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.